Stay updated on Pembrolizumab in Recurrent PCNSL Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Recurrent PCNSL Clinical Trial page.

Latest updates to the Pembrolizumab in Recurrent PCNSL Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedAdded revision note: v3.5.0. Removed revision note: v3.4.3.SummaryDifference0.1%

- Check17 days agoChange DetectedRevision history updated to include v3.4.3 and remove v3.4.2.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check46 days agoChange DetectedAdded Revision: v3.4.2 and removed older notices (including the lapse in government funding notice and Revision: v3.4.1), which are cosmetic updates and do not modify the study details or core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check53 days agoChange DetectedThe page now includes a government funding lapse notice with a status update for the NIH Clinical Center, and the site version was updated to v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check60 days agoChange DetectedThe page adds a Show glossary option and updates metadata labels (Last Update Submitted that Met QC Criteria; Revision: v3.4.0), replacing the previous labels (Last Update Submitted that met QC Criteria) and the No FEAR Act data note.SummaryDifference0.2%

- Check74 days agoChange DetectedRevision history updated: added Revision v3.3.4 and removed Revision v3.3.3.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Recurrent PCNSL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent PCNSL Clinical Trial page.